BBIO vs PEG · rev $221.9M vs P/E 18, rev $10.29B
BridgeBio Pharma Inc (BBIO) versus Public Service Enterprise Group Inc (PEG) — a side-by-side from cached financials, not a winner call.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Public Service Enterprise Group Inc (PEG) is a utilities - regulated electric company listed on NYSE.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
Latest reported PEG revenue for 2024-12-31 was $10.29B. Net income was $1.77B. Revenue was down 8.4% from 2023-12-31 to 2024-12-31. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
BBIO currently screens at market cap $13.24B. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
Not investment advice. Open the BBIO and PEG stock pages for the full models.
Not investment advice.